Universal Health Services Inc Reports Strong Q1 2026 Financial Results

In a significant boost, Universal Health Services saw its net revenues rise by 9.6% to $4.495 billion in Q1 2026, compared to $4.100 billion in Q1 2025. This growth was driven by robust performance across multiple service lines, particularly in acute and behavioral health care services.

On an adjusted basis, the net income for the first quarter of 2026 was $346.5 million, equating to $5.62 per diluted share, up from $319.5 million or $4.84 per diluted share in the prior year. The favorable tax impact recorded in connection with ASU 2016-09 contributed positively to the results, providing a net benefit of $2.2 million or $0.03 per diluted share.

The company reported an EBITDA net of noncontrolling interests of $651.7 million for the first quarter of 2026, an increase from $603.9 million a year earlier. Adjusted EBITDA, which excludes other income and expenses, was $648.3 million, reflecting a growth from $598.2 million in Q1 2025.

For the acute care segment, adjusted admissions remained stable on a same-facility basis, while adjusted patient days increased by 0.8% compared to Q1 2025. Notably, net revenue per adjusted admission rose by 6.3%, and net revenue per adjusted patient day grew by 5.5%. Overall, net revenues from acute care services increased by 8.2% year-over-year.

In the behavioral health segment, adjusted admissions grew by 1.2%, with adjusted patient days up by 1.6%. The revenue per adjusted admission and patient day also saw increases of 6.2% and 5.8%, respectively, leading to a 7.3% rise in net revenues from behavioral health care services.

Universal Health Services reported a solid increase in net cash provided by operating activities, amounting to $402 million for the first quarter of 2026, compared to $360 million in Q1 2025. The growth in cash flow resulted from a combination of factors, including a $40 million increase in net income and favorable changes in accounts receivable.

In a strategic move, Universal Health Services amended its credit agreement in April 2026, increasing its borrowing capacity by $900 million. This includes an expansion of its revolving credit facility and the introduction of a $400 million delayed draw term loan A, which is anticipated to be utilized for the acquisition of Talkspace, Inc..

As of March 31, 2026, the company had approximately $373 million in borrowings outstanding on its revolving credit facility.

During the first quarter of 2026, Universal Health Services repurchased 675,000 shares of its Class B Common Stock at an aggregate cost of approximately $127.3 million, averaging $189 per share. As of the end of Q1 2026, the company had an available repurchase authorization of about $1.298 billion.

Universal Health Services will host a conference call for investors and analysts at 9:00 a.m. ET on April 28, 2026, to discuss these results in detail. The company continues to be optimistic about its growth trajectory in the healthcare sector and remains committed to enhancing shareholder value.

As the healthcare landscape evolves, Universal Health Services' strong financial performance indicates a resilient operational model capable of adapting to new challenges and opportunities in the market.